|
| | Publication Year | Title | Author(s) |
| 1 | 15-Dec-2003 | Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. | Johns, Terrance G; Luwor, Rodney B; Murone, Carmel ; Walker, Francesca; Weinstock, Janet; Vitali, Angela A; Perera, Rushika M; Jungbluth, Achim A; Stockert, Elisabeth; Old, Lloyd J; Nice, Edouard C; Burgess, Antony W; Scott, Andrew M |
| 2 | 17-Mar-2005 | The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. | Johns, Terrance G; Mellman, Ira; Cartwright, Glenn A; Ritter, Gerd; Old, Lloyd J; Burgess, Antony W; Scott, Andrew M |
| 3 | 7-Oct-2002 | Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871. | Liu, Zhanqi; Lee, Fook-Thean; Hanai, Nobuo; Smyth, Fiona E; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M |
| 4 | 28-Mar-2005 | Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. | Panousis, C; Rayzman, V M; Johns, T G; Renner, C; Liu, Z; Cartwright, Glenn A; Lee, Fook-Thean; Wang, D; Gan, Hui K ; Cao, D; Kypridis, A; Smyth, Fiona E; Brechbiel, Martin W; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M |
| 5 | 1-Oct-2005 | Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. | Lee, Fook-Thean; Mountain, Angela J; Kelly, Marcus P; Hall, Cathrine; Rigopoulos, Angela; Johns, Terrance G; Smyth, Fiona E; Brechbiel, Martin W; Nice, Edouard C; Burgess, Antony W; Scott, Andrew M |
| 6 | 8-Nov-2006 | The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. | Gan, Hui K ; Walker, Francesca; Burgess, Antony W; Rigopoulos, Angela; Scott, Andrew M ; Johns, Terrance G |
| 7 | 9-Apr-2004 | Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor. | Johns, Terrance G; Adams, Timothy E; Cochran, Jennifer R; Hall, Nathan E; Hoyne, Peter A; Olsen, Mark J; Kim, Yong-Sung; Rothacker, Julie; Nice, Edouard C; Walker, Francesca; Ritter, Gerd; Jungbluth, Achim A; Old, Lloyd J; Ward, Colin W; Burgess, Antony W; Wittrup, K Dane; Scott, Andrew M |
| 8 | 15-Jul-2001 | Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. | Luwor, R B; Johns, T G; Murone, Carmel ; Huang, H J; Cavenee, W K; Ritter, G; Old, Lloyd J; Burgess, Antony W; Scott, Andrew M |
| 9 | 1-Jun-2001 | Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. | Lee, Fook-Thean; Rigopoulos, Angela; Hall, C; Clarke, K; Cody, S H; Smyth, Fiona E; Liu, Z; Brechbiel, Martin W; Hanai, N; Nice, Edouard C; Catimel, B; Burgess, Antony W; Welt, S; Ritter, G; Old, Lloyd J; Scott, Andrew M |
| 10 | 1-Oct-2001 | Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. | Scott, Andrew M ; Lee, Fook-Thean; Hopkins, Wendie; Cebon, Jonathan S ; Wheatley, J M; Liu, Z; Smyth, Fiona E; Murone, Carmel ; Sturrock, S; MacGregor, Duncan; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, Martin W; Davis, Ian D; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, Geoffrey ; Ritter, G; Hoffman, E W; Burgess, Antony W; Old, Lloyd J |
| 11 | 1-Sep-2005 | Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. | Perera, Rushika M; Narita, Yoshitaka; Furnari, Frank B; Gan, Hui K ; Murone, Carmel ; Ahlkvist, Marika; Luwor, Rodney B; Burgess, Antony W; Stockert, Elisabeth; Jungbluth, Achim A; Old, Lloyd J; Cavenee, Webster K; Scott, Andrew M ; Johns, Terrance G |
| 12 | 12-Aug-2004 | The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. | Luwor, Rodney B; Zhu, Hong-Jian; Walker, Francesca; Vitali, Angela A; Perera, Rushika M; Burgess, Antony W; Scott, Andrew M ; Johns, Terrance G |
